HOUSTON, July 29, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the company has received approval for the t

MINNEAPOLIS, July 29, 2019 /PRNewswire/ -- The Manova Global Summit on the Future of Health, has released new names for the speakers of this year's event. Among the participating presenters are:

MECHANICSBURG, Pa., July 29, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") proposes to commence an offering through a private placement, subject to market and other conditions, of $500 million in aggregate principal amount of senior notes due

MALVERN, Pa., July 29, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), the developer of NeuroStar® Advanced Therapy, the market leader in transcranial magnetic stimulation (TMS) for depression, announced today the launch of its TrakStar® Plus patient data management system. Building on the existing TrakStar Cloud™ system, this new release includ

DUBLIN, July 29, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today a partnership with actress, musician and producer Ashley Tisdale, bringing awareness to the digital-first 'Women Who Know' campaign that inspires women who are writing their own futures to take charge of their decisions when it comes to reproductive health and co

SAN DIEGO, July 29, 2019 /PRNewswire/ -- Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV)

MADISON, Wis., July 29, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $199.9 million and screened approximately 415,000 people with Cologuard during the quarter ended June 30, 2019. Second-quarter 2019 revenue and test volume grew 94 percent a

REDWOOD CITY, Calif., July 29, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended June 30, 2019.  The company's earnings call and webcast previously scheduled for Thursday, August 1 will now occur

SAN FRANCISCO, July 29, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced positive topline results from its pilot effectiveness study of KIND-016, a fully caninized, high-affinity monoclonal antibody targeting interleukin-31 (IL-31), for the tr

PRINCETON, N.J., July 29, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the European Patent Office has issued two patents, both titled "Topically Active Steroids